Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders

NCT: NCT06112067 · RECRUITING

NCT IDNCT06112067
StatusRECRUITING
Start Date2023-10-16
Completion2026-12
SponsorShanghai Mental Health Center (OTHER)
First posted
Last updated

Brief Summary

This is a multi-center, single arm, prospective, open-label, extendable study for the efficacy and safety of combo-stim deep brain stimulation for treatment-refractory mental disorders (obsessive-compulsive disorder, schizophrenia, bipolar with depression, anorexia nervosa, gambling disorder and adult autism).

Frequently Asked Questions

What is Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders?

Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders is a clinical trial registered under NCT06112067. Current status: RECRUITING.

What is the status of NCT06112067?

The current status of NCT06112067 (Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders) is: RECRUITING.

When did Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders start?

Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders started on 2023-10-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑